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I'VE SEEN ENOUGH!
MY LIFE AND TIMES IN HEALTH CARE
LAW AND POLICY
Clark C. Havighurstl
THE INVITATION TO PARTICIPATE in this symposium en-
couraged prospective authors, if they wanted, to comment on both the
origins of health care law as a scholarly and practice specialty and
their personal experiences in the field. Because my career as a legal
scholar, beginning in the mid-1960s, has coincided almost perfectly
with the field's emergence and maturation, I feel comfortable in offer-
ing this autobiographical essay, hoping it will be of some interest and
value to those who missed the excitement, and possibly some of the
lessons, of the field's formative years.' The essay also includes re-
flections on the current state of health care law and policy and on
some intellectual blind spots that influence thinking in the field.
Serendipity alone accounts for my making a career of critically
studying the legal environment of the U.S. health care industry.2
Unlike the highly prepared young law teachers of today, I embarked
on an academic career with no specific scholarly agenda in mind. In
fact, one of the attractions of the job offered at Duke was that I would
not be expected to plunge immediately into research and writing of
my own. Instead, my initial appointment contemplated that, in addi-
t Professor of Law and William Neal Reynolds Professor of Law (Emeri-
tus), Duke University. Given the nature of this essay, I have had to refer my own
work even more than usual. Rather than citing each item mentioned, however, or the
many others that might have been, I have (with the permission of the editors) deemed
it more efficient to call readers' attention to my bibliography accessible through the
Duke Law School website: http://www.law.duke.edu.
+ At the author's request, some of this article's formatting is inconsistent
with Bluebook rules and Health Matrix style policies.
I was also tempted, I admit, by the chance to use the essay's main title,
which once occurred to me as a great one for somebody's autobiography-not mine,
but someone's.
2 1 wonder how many other legal scholars working in the health care field
conceive their purview in just this global way. Some, I sense, focus less on trying to
understand how law and the legal system frustrate, or might better facilitate, the in-
dustry's good overall performance and more on either vindicating individual rights or
simply addressing discrete legal issues as they arise.
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tion to teaching such subjects as antitrust, regulated industries, securi-
ties regulation, and administrative law, I would serve for a few years
as faculty editor of Duke's venerable quarterly, Law and Contempo-
rary Problems (L&CP). The assignment to produce in each issue a
symposium of commissioned articles on a general topic I would select
appealed to me precisely because, although I had already published
some substantial practitioner-oriented things (including a book on
deferred compensation plans and articles on federal tax liens and em-
ployee stock options), I had not yet identified a field of long-term
scholarly interest. I have always considered it fortunate that, in my
early years in academe, I had the opportunity to dabble in many fast-
moving areas of law and policy and to learn from experts in many
disciplines, while honing my own writing skills in editing their work.3
I first stumbled into law and medicine (as the field was then
called) when the dean suggested that I prepare an L&CP symposium
in conjunction with Duke's medical school. That project, which re-
sulted in a 1967 issue entitled "Medical Progress and the Law," re-
quired more than the usual amount of substantive immersion in the
field because several of the papers I commissioned were of disap-
pointing quality, forcing me to scramble either to improve them, if
possible, or to find last-minute replacements. This early exposure to
the intersection of law and medicine would have led me no further
into the field, however, if individuals in the Department of Health,
Education and Welfare (HEW) had not been looking for a way to
stimulate legal scholarship related to health care. Because the L&CP
symposium bearing my name as editor was the precisely the kind of
thing they hoped to encourage, I received an exploratory phone call
from Laurence Tancredi, a young physician staffer at HEW (who
later, with my encouragement, got a law degree at Yale and became
himself a significant early player in the field of health care law). Our
conversations led ultimately to a modest contract under which I under-
took to start some balls rolling in health law scholarship. (The subse-
quent outpouring of such scholarship suggests-post hoc, ergo prop-
ter hoc-that our little project paid huge dividends.)
Under my contract with HEW, I created in 1969 the interdiscipli-
nary Committee on Legal Issues in Health Care, which operated until
1974 and included such leading figures from the legal world as Guido
Calabresi, William Curran, Frank Grad, and Nathan Hershey as well
3 Although I gave up the editorship of L&CP in 1970 (regrettably, it no
longer has a faculty editor), I have had many later occasions to write for it and to edit
additional symposia. Indeed, since L&CP's inception in the same year I was born, I
have published more pages in it than any other author.
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as such other luminaries as Henry K. Beecher, Reuben Kessel, Louis
Lasagna, and David Mechanic. The memoranda we prepared to elicit
the interest of law review editors in health care topics resulted in the
publication of a number of student-written articles and also led to my
own first publication in the health care field, a 1970 article in Science
entitled "Compensating Persons Injured in Human Experimentation."
That article, a simple application of Calabresi's theorizing about the
potential value of strict liability in optimally deterring accidents, also
revealed my emerging interest, developed in part while editing L&CP,
in law and economics.
But even these early engagements with the health care field might
not have been enough to inspire me to make a life-long commitment
to health care scholarship. After all, the salient legal issues in health
care in the late 1960s were still only the traditional concerns of law
and medicine-malpractice, hospital liability, occupational licensure,
prescription drug regulation, abortion, informed consent, and a variety
of other questions that now fall under the heading of bioethics. These
subjects, though certainly interesting to me, overlapped only a little
with my long-term teaching interests in antitrust law and economic
regulation and my developing scholarly interest in law and economics.
It was only when I heard about the new interest among policy makers
in health maintenance organizations (HMOs)-from two of Paul Ell-
wood's minions, at a memorable (to me) meeting at HEW in January
1970-that I began to see clearly how my fascination with competi-
tive markets as a non-governmental way to promote and channel
change and to resolve intractable trade-offs and conflicts in the society
might have some practical bearing on U.S. health policy and inspire
some useful legal scholarship.
This new dimension of my interest in the health care industry was
first manifest in a landmark two-volume symposium in L&CP spon-
sored by the Committee on Legal Issues in Health Care and published
in 1971. In addition to two provocative forewords in which I argued
for the market alternative in health care as few others had yet done,
that symposium included my first major article on a health care topic,
a lengthy piece entitled "Health Maintenance Organizations and the
Market for Health Services." If for no other reasons, that article was
notable because it used the word market in its title-a word that had
rarely, if ever, turned up in bibliographies concerning health care-
and because it suggested why antitrust law was potentially relevant to
the health care sector. Subsequent developments certainly bore out
my instinct that viewing health care as a potentially competitive "in-
dustry," and not as a monolithic, professionally controlled "system,"
would prove fruitful as a foundation for future scholarly endeavor.
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Looking back on my intellectual development in those years, I
count it a benefit that I did not come up through the ranks in law and
medicine, absorbing conventional values and wisdom along the way.
Indeed, I think the health care field needed a perspective like the one I
brought to it, since it appears to attract mostly persons with authoritar-
ian/collectivist, rather than pluralist, leanings. Relatively few health
law scholars, for example, seem willing or able to contemplate a legal
system that, rather than focusing principally on achieving desirable
substantive outcomes, concentrates on the integrity of the process
through which people make consequential choices for themselves.4
Yet in the absence of a plenary prescriptive or regulatory regime es-
tablished by legislation, the law's principal function is most appropri-
ately viewed as maintaining an open, fraud-free market in which even
intractable, value-laden choices can be made, as reliably as reasonably
possible, by the people most nearly affected, acting either as individu-
als or in groups or through selected agents-professional or corporate,
nonprofit or commercial, as the case may be. 5
4 Interestingly, scholars who are skeptical about letting consumers make
crucial choices about their own health care usually make exceptions for informed-
consent situations and abortion, presumably because there are no corporate intermedi-
aries and the operative values do not include economizing-they are quick to defend
individuals' right to choose. As I would, too. But see note 10 infra.
5 To appreciate how hard it is for some legal scholars to imagine-let alone
help foster and create-either a market for health care in which people truly choose
for themselves or a legal system that does not in some way preempt the most impor-
tant choices, see M. Gregg Bloche, The Invention of Health Law, 91 CAL. L. REV. 247
(2003). Bloche's article "challenges the proposition that we can resolve legal contro-
versies in the health care sphere through traditional economic reasoning," id. at 253,
which he understands to require consulting welfare economics "for clear answers to
scientific and moral questions about medical care's efficacy and value that our society
has not been able to resolve." Id. at 321. Bloche, it seems, cannot conceive of a legal
system that concentrates on maintaining a workable market, with incentives that do
not distort choices unduly, and that then accepts the results of that black-box process
as presumptively appropriate-i.e., efficient. Nor does he appreciate that, just maybe,
decisions that have no ultimately satisfying or universally correct answers are pre-
cisely the kind of choices that should be left in private hands, not resolved according
to positive law. Moreover, Bloche, like many others in our profession, is quite com-
fortable with having non-accountable judges serve as the ultimate arbiters of policy
and outcomes, rather than merely as interpreters of legislation prescribing specific
rights or obligations or, in the absence of such positive law, as guardians and facilita-
tors of processes that allow individuals and their selected agents to make the conse-
quential choices. For example, Bloche's conclusion on the courts' role in inventing
health care law includes the instruction that "when judges choose, as they must, be-
tween competing priorities, they should make the normative basis for their choices
explicit." Id. at 321 (emphasis added). See also id. at 290-94 (viewing the function
of judicial review of health plans' coverage decisions as ensuring economic rational-
ity and neglecting the possibility of anything other than de novo review of such deci-
[Vol. 14:107
I'VE SEEN ENOUGH!
My L&CP article on HMOs attracted support from a foundation
run by Ellwood, the originator of the HMO strategy, and enabled me
to serve during a sabbatical year (1972-73) as a scholar in residence at
the newly established Institute of Medicine (IOM) of the National
Academy of Sciences. This sabbatical proved to be a unique opportu-
nity to become acquainted with many insiders in the health policy
community and to discuss competition's role and antitrust issues with
them at a time before interest groups felt seriously threatened by these
policy ideas and political lines hardened. 6 It also led to my later in-
volvement in a number of IOM activities, including service as the
only legal scholar on its Board of Health Care Services from 1987 to
1997.
Among my projects during my year at the IOM was an article
with Tancredi proposing a limited strict-liability approach to compen-
sating certain iatrogenic medical injuries. This article, subtitled "A
No-Fault Approach to Medical Malpractice and Quality Assurance,"
again reflected Calabresi's theories concerning the incentive effects of
tort liability. The Havighurst-Tancredi proposal, which I developed
further in later writing and which received some serious attention in
the late 1970s, 7 still strikes me as having at least as much merit as
anything that has come since on the subject of medical malpractice
reform.8
sions, such as review to ensure that the plan's interpretation of its contract was not
unreasonable, arbitrary, or capricious); id. at 295 n. 163 (indicating the author's com-
fort with courts deciding the legality of restraints of trade on the basis of their view of
a restraint's probable effects on consumer welfare, not on the basis of its effect on
competition, the process that the Sherman Act was intended to foster and protect).
6 Some might think it more than a coincidence that in 1939, at the age of six,
I accompanied my father, also a law professor, to Washington on a sabbatical leave
during which, working for Thurman Arnold in the Antitrust Division of the Justice
Department, he helped to write the government's brief in United States v. Am. Med.
Ass'n (AMA), 110 F.2d 703 (D.C. Cir. 1940), the first appellate round of the famous
antitrust case in which the AMA was convicted of conspiring against an early HMO.
However, that case was virtually the only exposure my father ever had to either anti-
trust law or the health care industry, and I would swear that I came to my interests by
the route described above, not through any parental influence. To be sure, my own
son, Craig, who was himself six years old during my 1972-73 sabbatical, eventually
developed an interest in health care. But that interest was purely journalistic-as a
reporter covering the health policy beat (including the Clinton reform effort) in Wash-
ington in the early 1990s. In any event, he has now switched his focus to the music
business, which he writes about in Nashville, Tennessee.
7 See Laurence R. Tancredi, Designing a No-Fault Alternative, LAW &
CONTEMP. PROBS., Spring 1986, at 277 (restating proposal and summarizing attention
given to it).
8 My later work on the general theme of strict liability for iatrogenic injuries
included a 1977 piece on liability for injuries caused by contaminated blood; that
article also included a put-down of some foolishly overstated ideas about the destruc-
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The IOM year also included service on an IOM committee that
developed a provocative policy statement on HMOs (including a criti-
cal evaluation of the federal HMO Act of 1973) 9 and participation in a
National Institutes of Health task force considering the implications of
the artificial heart.'l The sabbatical also gave me a chance to begin
studying in depth the new regulatory programs then being put in place
in an attempt to overcome the apparent problems generated by third-
party payment for health care. My teaching and reading in the field of
regulated industries had sensitized me to the destructive consequences
of entry controls in other industries, thus making me skeptical about
certificate-of-need (CON) requirements for health facilities and ser-
vices. Sometimes called "health planning with teeth," CON regula-
tion was sweeping the country in the early 1970s, in a movement that
culminated in major federal health planning legislation in 1974. 1
Almost the first serious questions about CON regulation were raised
in June 1972 at a conference I organized for the American Enterprise
Institute for Public Policy Research (AEI)-beginning an association
with AEI that proved highly valuable to me in later years. During my
year at the IOM, I edited the AEI conference proceedings for subse-
quent publication and wrote a lengthy critique of CON laws for the
Virginia Law Review. This work laid the groundwork for additional
evaluations of regulatory initiatives in the health care sector through-
out the rest of the decade and beyond.
Continuing government grants allowed me, throughout the 1970s
and into the 1980s, to employ at Duke a series of younger colleagues
tiveness of the profit motive advanced in a much-too-well-received book, ROBERT M.
TITMUSS, THE GIFT RELATIONSHIP: FROM HUMAN BLOOD TO SOCIAL POLICY (1971).
The lessons drawn there concerning the legitimizing and incentive value of liability
have a bearing, it now occurs to me, on recent experience with managed health care,
as discussed in the text at notes 36-37 infra.
9 INST. OF MED., HEALTH MAINTENANCE ORGANIZATIONS: TOWARD A FAIR
MARKET TEST (1974).
10 Clark C. Havighurst, Separate Views of Professor Havighurst, in
ARTIFICIAL HEART ASSESSMENT PANEL, NATIONAL HEART AND LUNG INSTITUTE, THE
TOTALLY IMPLANTABLE ARTIFICIAL HEART 231 app. D (1973). Although I very much
enjoyed that foray into the technological future and the domain of bioethics, the cited
statement shows that it left me unsatisfied by the ability of bioethics to frame ques-
tions and therefore disinclined to pursue future issues from that perspective. In gen-
eral, I have long sensed that bioethics is too often an exercise in noblesse oblige and
that the choices it so consistently insists that people be given come too late in the
game, after they have become dependent patients and not at a time when they are still
independent consumers with some reason to be concerned how their resources are
spent.
11 National Health Planning and Resources Development Act of 1974, Pub.
L. No. 93-641, 88 Stat. 2225.
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to work on various projects. Randall Bovbjerg launched his career in
this way, exploring among other topics the conceptually important
question whether medical care provided under the auspices of an
HMO should be held, in malpractice cases, to the same costly legal
standard of care that applies in the unconstrained fee-for-service sec-
tor.12 A grant also helped to support a visit to Duke by James Blum-
stein in 1974-75, during which he and I wrote (with Bovbjerg's
help 13) a major article in the Northwestern University Law Review
discussing "quality/cost trade-offs in medical care." The word trade-
offs in the article's title signified the directness of our challenge to the
conventional view that health care should be delivered only according
to "need," without regard to cost. To this day, Blumstein and I remain
surprised at how few of our colleagues in health care law, despite our
graphic demonstration of the need to take the battle into "the qual-
ity/cost no man's land," have significantly acknowledged any need for
the legal system to accommodate private economizing when anything
other than pure "fat" might be cut. Mostly, it seems to us, health law
scholars want to change the subject, from the appropriateness of al-
lowing subsidized consumers to economize at the margin, to some-
thing they are more comfortable in discussing-the imperfections of
the market for health care and the ineptitude of consumers as decision
makers. I have always been struck how critics of my work, in easily
discounting the utility of markets because they are imperfect, do ex-
actly what they (usually inaccurately) accuse proponents of market-
oriented policies of doing-namely, using the unrealistic textbook
model of perfect markets, with its assumption of informed, rational
choice, as the basis for choosing a policy strategy. Their faith in their
own preferred mechanisms of social control-government, the courts,
and professional standards-still strikes me as more naive by far than
my idea that markets and consumers' appropriately subsidized choices
might reliably guide the health care industry toward efficiency in its
use of scarce resources. Indeed, the market strategy is most likely to
fail not so much because of any inherent deficiencies of markets or
consumer choice as because government and the legal system-which
are far less effectively accountable to informed, rational voters than
market actors are to informed, rational consumers-impede its reali-
zation by catering to special interests, by distorting incentives, by lim-
12 Randall Bovbjerg, The Medical Malpractice Standard of Care: HMOs and
Customary Practice, 1975 DUKE L.J. 1375.
13 The three of us collaborated on another major article that year, a piece in
L&CP that addressed the symbolic importance of health spending and health policy
under the title, "Strategies in Underwriting the Costs of Catastrophic Disease."
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iting consumers' options, and by invalidating even rational economiz-
ing choices ex post in order to minimize apparent hardship.1
4
In the mid-1970s, health policy debates focused mostly on the
need for and design of economic regulation for the health sector, in-
cluding not only health-planning and CON programs and regulation of
hospital prices but also various methods to control the overutilization
of services. I was well positioned to recommend rethinking the desir-
ability of regulating health care, both because I knew something about
other industries' poor experiences with utility-type regulation and
because I could visualize how an unregulated health care industry
might work. My arguments were better received than they might have
been at another time because many economists and some liberal crit-
ics were beginning to find much economic regulation to be highly
problematic. The problem of industry "capture" of its own regulatory
apparatus was soon seen to be not merely a potential problem in
health care but, in the form of professional self-regulation, already a
source of severe restrictions on various actors' competitive freedom.
Thus, the occasion for my "trade-offs" article with Blumstein was the
appearance of Professional Standards Review Organizations (PSROs),
which Congress created in 1972 so that entities accountable to the
medical profession could both set quality standards and define what
services should be paid for under federal health programs. In addi-
tion, Bovbjerg and I published an article criticizing the decision of
Congress to subject HMOs serving Medicare patients to the jurisdic-
4 Paul Starr, in an important 1982 prognostication, doubted that the market
strategy would succeed as a public policy for the health care sector because it was
unlikely to be implemented, even by the conservative Reagan administration, as a
serious competitive strategy. PAUL STARR, THE SOCIAL TRANSFORMATION OF
AMERICAN MEDICINE 419 (1982). See also id. at 442 (cautioning that competition
among various types of corporate medical care is extraordinarily sensitive to the
vagaries of politics). In a forthcoming article, I state,
To be sure, Starr might have said in 1982, with accuracy, that it was unreal-
istic for advocates of [market-oriented] policies to expect the American po-
litical and legal system to hit upon a clear, coherent policy and to execute it
consistently. Those advocates might have replied, however, that such po-
litical realism, while generally warranted, constitutes a self-fulfilling proph-
ecy that dooms the best ideas at the starting gate, ensuring that policies of
all kinds will be second-best at best. If taken to heart, Starr's realism, born
of observing organized medicine at work in many circumstances, would
have forced would-be revolutionaries into self-imposed compromises with
reactionary forces.
Starr on the Corporatization and Commodification of Health Care: The Sequel, 29 J.
HEALTH POL., POL'Y & L. (forthcoming 2004). The cited article goes on to argue (in
an implicit defense of my own revolutionary activities) that the market strategy was
attractive and revolutionary enough that it deserved a chance to succeed, even against
great political odds.
[Vol. 14:107
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tion of PSROs, expressing the concern that, given authority over
HMOs, professionalist PSROs would prevent them from providing
useful competition for the fee-for-service sector. In general, the pe-
riod was one in which it was sobering to bring political and economic
insights from other regulated industries to bear on emerging federal
and state policies in the health care sector.
Although I saw major problems with the regulatory approach,
competition was not an entirely plausible alternative to regulation in
the early 1970s because of the power that the organized medical pro-
fession exercised over many features of the system. The most imme-
diate concern was the profession's ability to resist collectively any
payer strategy that physicians did not like. Recognizing the impor-
tance of bringing antitrust law to bear on such professional dominance
and obstructionism, I wrote a brief amicus curiae (pro se) in 1974
urging the Supreme Court to grant certiorari in the Goldfarb case, in
which the lower court had refused to apply the Sherman Act to price
fixing by lawyers in Virginia.' 5 My argument that the case was of
crucial importance not only for the market for legal services but for
the health care industry as well was certainly borne out by subsequent
events. Together with several decisions extending the reach of the
federal commerce power in markets for professional services, the
Court's 1975 ruling that the "learned professions" enjoyed no exemp-
tion from antitrust law invited the antitrust enforcement agencies to
challenge a variety of anti-competitive practices that had developed in
medicine when antitrust law's applicability was unclear. Equally im-
portant, the availability of antitrust law to discipline providers made it
much more realistic to contemplate a federal health policy relying
heavily on competition. Indeed, in the late 1970s, the policy debate,
which had previously been largely about whether the medical profes-
sion or government regulators should have the upper hand, began to
recognize that there was a third way to tackle the nation's problem
with rising health care costs. In the ensuing years, I was active in
spelling out and advancing that policy agenda. In 1982, Business
Week portrayed Ellwood, Alain Enthoven, Walter McClure, and me as
a "Gang of Four" advocating a market-driven strategy. ' 6
In 1978-79, 1 was again in Washington on a sabbatical leave, this
time as a resident consultant at the Federal Trade Commission (FTC),
which was actively considering how to enforce the antitrust laws in
the health care sector. At that time, too, policy makers' interest in
15 Goldfarb v. Va. State Bar, 497 F.2d 1 (4th Cir. 1974), rev'd, 421 U.S. 773
(1975). 6 The Spiraling Costs of Health Care - Rx: Competition, Bus. WK., Feb. 8,
1982, at 58.
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"deregulation," which had gained significant traction in several previ-
ously regulated industries, finally began to extend explicitly to health
care. In particular, the health sector attracted attention in the White
House's war against inflation, which was presided over by Alfred
Kahn, famous for having dismantled the Civil Aeronautics Board.
Significantly, in May 1979, Congress defeated the Carter administra-
tion's centerpiece proposal to impose a national cap on the growth of
hospital revenues, thereby signifying that it was giving up on trying to
regulate private health care costs. Members also began to think and
talk openly about a market-oriented health policy and to propose
measures to strengthen competition in health care. In addition to par-
ticipating in debates over hospital regulation, I had a significant role
in helping Congress prepare the 1979 amendments to the 1974 health
planning legislation.17 Those amendments included language, which I
helped to draft, that for the first time expressed a favorable congres-
sional view of competition's potential in the health care sector. I de-
scribed the flow and ebb of health planning and CON regulation in
(among other places) a 1982 book, Deregulating the Health Care In-
dustry: Planning for Competition.
An important theme in my work in the late 1970s and early 1980s
was the potential for the private sector to bring some rationality to
health care spending. In testimony prepared in 1976 for the Council
on Wage and Price Stability, 8 I observed, as others were beginning to
do, how the tax treatment of employer-purchased health insurance
induced over-insurance, greatly expanding the range of services sub-
ject to moral hazard and diminishing the returns from cost-
containment efforts that private payers might undertake. In that
statement and later writings (some of them co-authored with Glenn
Hackbarth, a former student and later a colleague in Duke's on-going
Program on Legal Issues in Health Care), I attempted to envision cost-
containment tactics that private payers might employ but had not to
date employed-seemingly because (1) the tax subsidy diminished
their incentive to do so, (2) the medical profession threatened to boy-
cott any payer that infringed professional prerogatives, and (3) compe-
tition had not yet pushed payers to take active responsibility for con-
trolling costs. Among other things, I insisted that any payer-
conventional insurers as well as HMOs and other so-called "alterna-
tive delivery systems"--could both obtain competitive prices from
17 Health Planning and Resources Development Amendments of 1979, Pub.
L. No. 96-79, 93 Stat. 592 (1979).
18 See Clark C. Havighurst, Controlling Health Care Costs: Strengthening
the Private Sector's Hand, I J. HEALTH POL. POL'Y & L. 471 (1977).
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providers and address the moral hazard problem by bargaining di-
rectly with providers over prices and methods of rationalizing the
utilization of services. In these articles observing opportunities for
"private cost containment," I advocated discarding the old notion,
fortunately embodied more in general practice (reflecting professional
preference) than in law, that health insurers should underwrite a pa-
tient's access to any provider he might choose.' 9 In other writings
during this period, I highlighted the trade restraints by which organ-
ized medicine had precluded health plans from assuming responsibil-
ity for the cost of care. I also take credit for stimulating two FTC
economists, Lawrence Goldberg and Warren Greenberg, to write a
much-cited article in which they analyzed the record in an early, un-
successful antitrust case against the Oregon State Medical Society,20
forcefully demonstrating how medical interests effectively stifled
some promising early innovations in prepaid health care.2'
As it turned out, selective contracting and preferred-provider ar-
rangements finally became standard practice in the industry in the
1980s. What turned the tide was, first, an important FTC action chal-
lenging not only professional restraints on physician advertising but
also ethical rules precluding so-called "contract practice. 22 Second,
the Reagan administration's decisive rejection of a regulatory agenda
sent employers and health insurers a clear message that private health
care costs would henceforth be their responsibility, not the federal
government's. At the same time, the administration shifted to pro-
spective payment for hospital services under Medicare, setting an im-
pressive example in aggressive "prudent purchasing" for the private
sector to follow. Developments on the private sector's demand side
then quickly disproved the claim that only regulation could check
growth on the supply side and otherwise control costs.2 3 As I had
19 See Charles D. Weller, "Free Choice" as a Restraint of Trade in Ameri-
can Health Care Delivery and Insurance, 69 IOWA L. REV. 1351 (1984) (discussing
how the AMA's "free choice" ethics effectively eliminates competition and the right
of a patient to choose a physician). Over the years, I have frequently shared thoughts
with Weller, an early and influential antitrust crusader against professional restraints
in health care.
20 United States v. Or. State Med. Soc'y, 343 U.S. 326 (1952).
21 Lawrence Goldberg & Warren Greenberg, The Effect of Physician-
Controlled Health Insurance: U.S. v. Or. State Med. Soc'y, 2 J. HEALTH POL. POL'Y
& L. 48 (1977).
22 AMA v. FTC, 638 F.2d 443 (2d Cir. 1980), aff'd by equally divided Court,
455 U.S. 1744 (1982).
23 After these claims were discredited, regulation could be defended only on
the expedient ground that price competition would undermine the capacity of certain
providers, especially hospitals, to cross-subsidize activities for which insurance was
not available to pay. In addition to escaping accountability of public financing
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argued in the Virginia Law Review in 1973, regulation had been aimed
only at suppressing the symptoms of a seriously dysfunctional pay-
ment system, a strategy favored by industry interests precisely be-
cause it gave the impression of control while protecting incumbent
payers and providers against pressures to change appreciably the ways
they did business. In the new era, even Blue Cross and Blue Shield
plans were soon forced by competition to act as purchasing agents for
consumers, rather than as friendly selling agents for organized provid-
ers.
By the mid-1980s, I had begun to believe that a true revolution
was in progress in American health care, one that would ultimately
give consumers effective agents through whom to confront previously
dominant providers and thereby obtain the benefits of both price com-
petition and provider accountability for wasteful or unwanted spend-
ing. Advancing this revolutionary cause required, among other things,
scholarly attention to the problem of applying conventional antitrust
doctrine to an industry whose services were generally financed
through insurance and that appeared to many to be so qualitatively
different from other competitive industries as to require special, softer
antitrust rules. Accordingly, I wrote numerous articles attempting to
clarify the application of antitrust principles to a wide variety of pro-
fessional activities, including the administration of staff privileges in
hospitals, peer review, personnel credentialing, technology assess-
ment, and the accrediting of institutions and educational programs.
On the last of these topics, I edited a 1994 symposium in L&CP enti-
tled "Private Accreditation in the Regulatory State." Although my
work on antitrust issues normally tended to favor aggressive enforce-
ment against professionals, a talk and an article written in 1995 were
somewhat critical of the enforcement agencies' policy in evaluating
physician networks. Presumably because I was known as a critic of
the profession, the American Medical Association featured my views
24on this subject in a full-page ad in the New York Times.
This is not the place to recount the successes and failures of the
antitrust campaign. To be sure, lower courts still tend to be soft on
many types of professional restraints, and a bare majority of the Su-
preme Court was shockingly so in California Dental Association v.
FTC.25 But for the most part antitrust principles have been adapted to
through the political process, however, such backdoor financing invites inefficient
operation and the provision of services that are not valuable enough to justify public
support.
24 N.Y. TIMES, Nov. 17, 1995, at Al1.
25 526 U.S. 756 (1999) (raising standard of proof needed to establish illegal-
ity of a professional association's restrictions on member advertising). My critique of
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the health care field without appreciably relaxing the law's rigorous
insistence on competition. In any event, I felt by the late 1980s that
the antitrust mission of breaking the power of the medical monopoly
was on its way to being accomplished fairly well, thus fulfilling a vital
condition for the revolution's ultimate success. I was sufficiently
encouraged that developments were progressing well in the direction
of empowering consumers that I wrote a piece in 1986 cautiously her-
alding the revolution. Its title was "The Changing Locus of Decision
Making in the Health Care Sector." Although that article spoke only
of the "decentralization" of decision making, I finally broached the
theme of actual revolution in a 1990 article, which I ended by observ-
ing a parallel between the fall of communism is Eastern Europe and
the weakening of "the medical profession's one-party rule" in Ameri-
can health care.
2 6
Also in the mid-1980s, I felt that the legal environment of the
health care industry had both changed and stabilized enough that it
could be effectively and usefully captured and presented in a new law
school casebook. In 1988, Foundation Press published the first edi-
tion of my Health Care Law and Policy: Readings, Notes, and Ques-
tions. Prepared single-handedly, the book appeared about one year
after the multi-authored first casebook explicitly focused on "health
law.",27 My book represented a greater departure from past texts,
however, because it made relatively little effort to address the tradi-
tional issues falling under the heading of "bioethics" and instead fo-
cused explicitly on the industry's recent commercialization and the
legal and policy issues raised by those developments. I also explicitly
presented the trade-off problem early in the text, so that business prac-
tices and legal rules encountered later could be examined in part from
an economic perspective. Moreover, instead of treating legal issues
under legal headings, I presented them as they arose from industry
practices, both past and present, or were suggested by emerging
trends. Thus, I introduced the application of antitrust law to profes-
sional services fairly early in the course because the antitrust cases
and developments teach so much-as they had taught me-about the
industry's history and new competitive environment. Once the stu-
dents had some basic antitrust knowledge, it was possible to address
the antitrust issues raised by specific business practices, such as the
this decision appears as part of a short history in Health Care as a (Big) Business: The
Antitrust Response, 26 J. HEALTH POL., POL'Y & L. 940, 949-53 (2001).
26 The Professional Paradigm of Medical Care: Obstacle to Decentraliza-
tion, 30 JURIMETRICS 415, 429 (1990).
27 BARRY R. FURROW ET AL., HEALTH LAW: CASES, MATERIALS AND
PROBLEMS (lst ed. 1987).
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denial of hospital staff privileges, as they came up in context later in
the course. Fortunately, I was able to persuade Jim Blumstein and
Troy Brennan to assist me in preparing the book's second (and much
improved) edition, which appeared in 1998. (A third edition is con-
templated.) I regard the casebook as a scholarly, not just a pedagogi-
cal, contribution and wish that more colleagues in the field, including
those who find the book too challenging for their students, would con-
sult the book and the accompanying teacher's manual for conceptual
guidance and insights.
Encouraged as I was about the revolution's progress in the early
1980s, I still saw obstacles to realizing its ultimate objective of em-
powering consumers. I worried, for example, that the intermediaries
on whom consumers would have to rely to represent their interests in
post-revolutionary markets did not have all the tools and freedom they
would need to make and enforce difficult trade-offs in administering
coverage in the interest of their subscribers. As early as 1983, in an
article about what I saw as an emerging challenge to "the prevalent
assumption that the health care system must operate under prescrip-
tive standards of acceptable care and appropriate spending," I warned
that would-be market reformers of the health care system "could go
wrong... by assuming too readily that interacting private parties and
institutions would be free and uninhibited in their competitive efforts
to translate consumer cost concerns into economizing behavior by
providers. 8 That article opened up a scholarly agenda that engaged
me on and off well into the 1990s. Specifically, it raised doubts about
the flexibility and utility of private contracts as vehicles for introduc-
ing alternative standards, rights, and obligations in the health care
field. The problem was not just explicit regulation, which by that time
was largely on the run. Instead, as I observed,
[d]octrines of private law-the law of torts and contracts-
may impose on private parties duties that are inconsistent with
both efficiency and the parties' contractually specified obliga-
tions. If such legal doctrines, originally designed to prevent
economically powerful interests from overreaching the con-
sumer, stand in the way of departures from prevailing stan-
dards of care and practice in the medical care field, market re-
28 Clark C. Havighurst, Decentralizing Decision Making: Private Contract
Versus Professional Norms, in MARKET REFORMS IN HEALTH CARE: CURRENT ISSUES,
NEW DIRECTIONS, STRATEGIC DECISIONS 22, 22 (Jack A. Meyers ed., 1983).
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formers' hopes of seeing consumers offered a full range of
choice are doomed to frustration.
29
I noted the irony that paradigms and legal doctrines ostensibly de-
signed to protect consumers against "economically powerful interests"
might prove instrumental in frustrating the movement to empower
consumers against the powerful dictates of both medicine and the le-
gal system, thereby perpetuating what I called "The Tyranny of Pro-
fessional Norms and Standards. 3 °
A related obstacle to the revolution's ultimate success was the
professional paradigm of medical care, which rejected the possibility
that health care might become a true consumer good in the sense that
people could purchase just the quantity (intensity) and quality of it
that they desired and could (with available subsidies) afford. In the
early 1980s, however, it began to seem that the paradigm might top-
ple. At that time, the work of John Wennberg 31 and David Eddy
32
made the policy community suddenly aware of unexplained variations
in medical practice and of the weak scientific foundation for many
services that doctors customarily prescribe. To my eye, these findings
revealed fundamental flaws in the professional paradigm, founded as
it was on trusting clinicians to translate scientific learning into sound
clinical policies. To my ear, they cried out for giving health plans
some freedom to set their own practice standards, rather than being
forced to pay for whatever some medical expert, consulting "profes-
sional standards," might declare to be "medically necessary." What
ensued, of course, was a campaign by organized medicine to reestab-
lish its credibility and maintain its authority over medical practice by
producing "clinical practice guidelines." But the new shakiness of
professional authority made it possible to imagine that the "locus of
decision making" might really shift decisively in the direction of con-
sumers.
In the middle of the 1980s, a new malpractice "crisis" attracted
legislative interest and occupied the time of many of us in the field of
health care law. Consistent with my view that people should be rea-
sonably free to choose the rules under which they receive professional
services, I wrote some articles promoting "private" malpractice re-
form-that is, contractual (rather than legislative or judicial) modifi-
29 Id. at 23 (emphasis added).
30 id.
31 E.g., John E. Wennberg, Dealing with Medical Practice Variations: A
Proposal for Action, HEALTH AFF., Summer 1984, at 6.
32 E.g., David M. Eddy, Clinical Policies and the Quality of Clinical Prac-
tice, 307 NEW ENG. J. MED. 343, 343 (1982) (finding reason to believe that there are
flaws in the process by which the profession generates clinical policies).
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cations of patients' rights and providers' obligations under the law of
torts. A major conference that Bovbjerg and I ran in Washington in
1985 and turned into a 1986 volume of L&CP focused substantially
on the potential for private reform, under the subtitle "Can the Private
Sector Find Relief?" My two articles in that symposium sought not
only to push the idea of contractual reform well beyond arbitration
clauses, the only place it had been favorably received, but also to con-
nect thoughts expressed by Richard Epstein in the 1970s 33 to trends in
modem health policy. One idea that still seems wise, though it has
had few takers, was that new rules governing medical injuries, instead
of being built into provider/patient contracts, should appear in the
subscriber contracts of competing health plans. Indeed, I went so far
as to suggest, among other things, that consumers might be offered
contracts establishing a standard of care different from the costly pro-
fessional one embodied in malpractice doctrine and drawn principally
from customary medical practice. As I argued in a 1991 article, again
in L&CP, the new availability of practice guidelines made this strat-
egy much more feasible than it would have been in earlier times.
Few of my projects have yielded less in terms of opening up new
policy possibilities than my efforts on behalf of contractual reform of
malpractice law. In retrospect, I can see how naive I was to think that
the legal monopoly, however much valid criticism it attracted, would
ever allow people to reject the rights it confers on them in favor of
something less costly. But it was my first direct encounter with the
power of the rights-based legal paradigm and of the trial lawyers who
defend it. Perhaps most surprising to me was to see how few of my
colleagues in the legal academy showed any enthusiasm for contesting
the legal system's monopoly over the rules governing medical inju-
ries. The majority seemed entirely comfortable with the idea that the
legal system is well-positioned to know what is good for people and
that, if change is to occur, it must come from within the legal system
itself, not from people choosing for themselves. Indeed, many who
had seemed to share my view that the medical profession should not
dominate decision making in the health care field had no similar res-
ervations about a legal system that aggressively monopolizes the mak-
ing of consequential choices. I sense that many academic lawyers are
threatened by market-oriented ideas in part because they value their
role as minor cogs in the machine that grinds out the rules by which
people are required to live.
33 Richard A. Epstein, Medical Malpractice: The Case for Contract, 1976
AM. B. FOUND. RES. J. 87.
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In 1989-90, I was on another sabbatical leave in Washington, this
time working as a part-time consultant in the offices of Epstein,
Becker & Green. Although the first Bush administration was a disap-
pointment to anyone who hoped to see renewed attention to health
policy, the practice guidelines movement was then entering a crucial
phase. During that year, I spoke and wrote (in the St. Louis University
Law Journal) approvingly of the medical profession's efforts to de-
velop guidelines. I also argued, however, that useful guidelines might
emanate from independent sources and be more prescriptive than the
profession would like. I also advanced the heretical view that an indi-
vidual health plan should be free to select the particular guidelines by
which it expected its doctors to abide. Indeed, I viewed guidelines as
a new technology that might finally enable a health plan to specify in
its contracts with subscribers just what services it and its providers
would undertake to cover or provide in particular clinical circum-
stances. Suddenly, I thought, health plans had the capability of offer-
ing consumers real, explicit alternatives, some with price tags much
less burdensome than the cost of care prescribed according to profes-
sional standards. Much of my work in the early 1990s was aimed at
promoting the use of creative contracts in aid of consumer economiz-
ing. A 1992 article, for example, was entitled, "Prospective Self-
Denial: Can Consumers Contract Today to Accept Health Care Ra-
tioning Tomorrow?"
Just as there were few takers for the idea of private malpractice
reform, most of the legal academy and the lawyers who advise health
plans apparently saw little merit (or promise) in my more general pro-
posals to empower consumers of health care by widening freedom of
contract. My 1995 book published by AEI Press, Health Care
Choices: Private Contracts as Instruments of Health Reform, at-
tempted to show why current health contracts are burdensome to indi-
viduals, how better contracts could be written, and why, with public
subsidies and normal legal protections, consumers would not be at
undue risk if health care finally became a true consumer good. The
book also recounted my effort to persuade the Clinton administra-
tion's task force on health reform to incorporate a substantial role for
private contracts in the legislation it was preparing. Although my
ideas found some sympathetic ears among task force members, egali-
tarian impulses were too strong at the task force's top, and the princi-
ples of "managed competition," as developed by Enthoven and the
Jackson Hole Group, were largely sacrificed in favor of a regulatory
agenda. I still believe, however, that adopting my suggestions would
have made the reform package more palatable to the voting public
than the administration's proposals turned out to be. In any event,
reform-by-contract remains available as a practical and reasonable
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way of finally realizing the goal of universal health coverage at af-
fordable prices. To date, however, private contract has not proved an
effective vehicle for empowering consumers in the health care mar-
ketplace. In a 2000 commentary on how professional standards and
not consumers' choices continue to drive the system, I observed the
irony "that the same legal system that with one arm launched an anti-
trust initiative successfully challenging overt efforts by the medical
profession to exercise decision-making authority in the health care
sector has, through its other arms, conferred on medical interests a
highly effective monopoly over the most important economic deci-
sions affecting American health care.",
34
My most recent work has, like this essay, been largely retrospec-
tive, aimed at helping the policy community understand why two dec-
ades of relying principally on market forces in health care, although
triggering a promising movement toward managed care, have not
turned out well. A symposium I edited for L&CP in 2002 posed the
question, "Is the Health Care Revolution Finished?" Unfortunately,
my answer to that question is affirmative, not because the revolution
had nothing more to offer but because it has been effectively rolled
back by its opponents. These opponents included, in addition to
counter-revolutionary interests in the medical profession, many in the
legal academy and policy community who also resist pluralism and
are similarly unwilling to see health care issues resolved in the mar-
ketplace. My own article in that symposium was titled "How the
Health Care Revolution Fell Short." Among other things, it explains
how the managed care industry itself, behaving opportunistically and
short-sightedly in a highly uncertain and changing political environ-
ment, failed to do its part. Specifically, I can now see why modern
health plans ultimately failed (1) to effectively integrate the provision
of health care with its financing and thus to manage trade-offs sensi-
tively in the interest of their subscribers; (2) to offer consumers a full
range of health care options, including not only expensive, ostensibly
high-quality care and coverage but also appreciably cheaper versions
of possibly lesser quality; and (3) to earn consumers' trust as their
post-revolutionary representatives and allies in the battle against high
health care costs and entrenched professional power.
One regret I have, looking back, is that I was not more attentive,
or attentive at a much earlier date, to the problem of making health
plans legally accountable when their enrollees fail to receive either the
quantity or the quality of care they were promised. Possibly, for ex-
34 Clark C. Havighurst, American Health Care and the Law-We Need to
Talk!, HEALTH AFF., July-Aug. 2000, at 84, 97.
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ample, I should have joined the debate over the scope of federal pre-
emption, under the Employee Retirement Income Security Act
(ERISA), 5 of state remedies against health plans that fail to honor
their contracts. To be sure, unlike my many colleagues who decried
the protection that ERISA-protected health plans enjoyed against law-
suits for personal injuries caused by erroneous denials of coverage, I
saw some benefit in leaving health plans free to address their moral
hazard problems without the risk that they would be unreasonably
second-guessed by state courts and juries. Moreover, I saw little con-
vincing evidence, either in the cases I read or in the anecdotes re-
ported in the press, that health plans, though sometimes wrong or in-
ept in administering their coverage, were acting in bad faith or inten-
tionally abusing their power to ration marginally beneficial care. But
the situation was clearly less than ideal and deserved more attention
than I gave it.
While I was probably right in my judgment that repealing ERISA
to subject health plans to more legal deterrence of erroneous benefit
determinations would have raised costs unjustifiably, I failed to an-
ticipate how ERISA preemption of enrollees' legal remedies might
distort the perspective and influence the behavior of the health plans
themselves. With little to fear from personal-injury lawsuits, they
paid less attention to building solid legal defenses for the methods
they were using to control costs. Not only did health plans fail to turn
square legal comers by writing contracts that explicitly authorized
those methods and by candidly explaining them in sales literature and
plan documents, but they appeared to conclude that they would stand
or fall only according to standards set by the political system and by
cost-conscious employers, their immediate customers. Macro-
accountability to government and large group purchasers was an in-
adequate substitute, it seems, for micro-accountability to individual
consumers and the courts. Indeed, as long as health plans are not ef-
fectively and reasonably accountable in a credible legal forum for the
way they administer their contracts in specific cases, the legitimacy,
and thus the efficacy, of contract itself, as a tool by which consumers
can exercise real choice, will remain fundamentally in doubt. The
alternative when contracts are not trusted is, of course, prescriptive
regulation, which has been gradually reasserting itself as-in the ab-
sence of well-drafted, enforceable contracts-the legitimacy of man-
aged care has been called into question. In a 2001 article in Health
Affairs, I expressed mild approval of certain class actions that had
been filed against managed-care firms. My thesis was that health
" 29 U.S.C. §§ 1003-1191 (2000).
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plans deserved some sanction, not for using particular methods to
ration care (as the plaintiffs maintained), but for inadequately disclos-
ing those methods in their advertising, contracts, and other plan
documents-that is, for hiding from their subscribers the de facto lim-
its they were placing on patient entitlements.
The accountability of managed-care organizations has another
important aspect as well, to which I gave substantial attention in the
mid-1990s but which I now think I should have emphasized much
sooner. To its credit, the Clinton health reform task force proposed
the radical idea of extending the principle of "enterprise liability" to
all managed-care organizations-that is, making the health plan ex-
clusively responsible in law for the negligence of its affiliated provid-
ers. Although I had not previously focused on this issue, I supported
the Clinton team's idea both in meetings it convened and in legislative
language I drafted for the task force's consideration. 36 Subsequently,
I refined my thinking in a pair of articles, finally concluding that "vi-
carious liability" is the preferable term and concept, because it pre-
serves the notion that it is still medical professionals, not the corporate
enterprise itself, whose performance is at issue. Indeed, the more I
thought about it, the more strongly I believed that plan accountability
for injuries caused by providers they selected is necessary to legiti-
mize managed care and that its absence was a key factor in managed
care's downfall in the 1990s. In a 2000 article, I finally recognized
what should have been obvious much sooner: the fundamental unten-
ability and instability of a health policy under which "corporate health
plans have assumed extensive responsibility for the cost of care with-
out accepting more than nominal responsibility for its quality."37
In retrospect, I regret that I did not have vicarious liability on my
reform agenda in the early 1980s, when, by better aligning the inter-
ests of plans and providers, it would have made a dramatic difference
in the way plans evolved. Indeed, I now think it probable that vicari-
ous liability would have promoted precisely the close integration of
plans and providers that was rarely achieved but that is vital to im-
proving quality and to efficiently and appropriately controlling cost.
Unfortunately, my early faith that logic and market pressures to
achieve efficiency would push health plans inexorably toward such
integration (and the law in turn toward recognizing the new reality)
took too little account of the staying power of the professional para-
36 See CLARK C. HAVIGHURST, HEALTH CARE CHOICES: PRIVATE CONTRACTS
AS INSTRUMENTS OF HEALTH REFORM, 59-60, 81-82 (1995).
37 Clark C. Havighurst, Vicarious Liability: Relocating Responsibility For
the Quality of Medical Care, 26 AM. J.L. & MED. 7, 13 (2000).
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digm of medical care, which had long opposed anything that smacked
of "corporate practice." I simply failed to appreciate the need for leg-
islation that would both legitimize and induce departures from the
paradigm. Clearly, as a fomenter of the health care revolution in the
1980s, I was not radical enough.
Although the revolution failed at many points to achieve its ambi-
tious goal of empowering ordinary consumers in the face of en-
trenched interests, the ultimate problem- as I now conclude (and
previously suspected, even while choosing not to give in to such a
counsel of despair)-is the political economy of American health care
law and policy. Whereas most analysts believe that health care mar-
kets are doomed to fail because consumers are ignorant concerning
the quality of care, a much greater problem is consumers' ignorance
concerning the cost of their health coverage. At least in the private
sector, this ignorance creates a special kind of moral hazard, which
enables employers, government, and the legal system to freely (or
almost freely) write costly prescriptions for which consumers must
ultimately pay. Strikingly, the ignorance of consumers-cum-
employees-cum-voters concerning the cost of the health care they
enjoy is not inevitable. Indeed, it is instructive to consider just whose
interests are served when government, by subsidizing health care indi-
rectly through the tax system, ensures that its costs will be well hidden
from those who pay them. My 2002 article in L&CP presents a model
of majoritarian and interest-group politics that shows convincingly
why the health care revolution never really had a chance. Specifi-
cally, it explains both the "over-regulation" of health care, that is, the
bevy of cost-increasing legal requirements that benefit the majority at
the expense of the (lower-income) minority-and its "hyper-
regulation"-that is, requirements that, once hidden costs are counted,
diminish the welfare of a supermajority of voters while yielding net
benefits only to the health care industry and its upper-income patrons.
To be sure, there were some years when the political cards were being
reshuffled and revolutionary change seemed truly possible. But those
cards are stacked again. Although I still feel a duty to advocate
change that would empower consumers at the expense of special in-
terests, I have fewer illusions than I used to have that market-based
democracy will eventually prevail, enabling consumers to govern the
system through their cost-conscious choices.
My latest work has also left me with a deeper appreciation of how
the American health care system oppresses ordinary Americans. In
addition to forcing them to contribute to financing a hyper-regulated
system with marginal benefits far more costly than most of them
would choose to pay for, the system is also, I now believe, scandal-
ously regressive in the way it distributes its seemingly egalitarian
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benefits. Among other likely sources of systematic regressivity-
besides regulatory standards biased against middle- and lower-income
premium-payers-are the following: employers' tendency to design
benefits to serve the interests and preferences of their higher-income
employees; providers' tendency to tailor clinical choices according to
patient expectations, which may vary in proportion to income and
education; discrepancies in the ability of higher- and lower-income
patients to "work the system," especially now that consumers possess
extensive appeal rights;38 the probable disparate impact of cost sharing
on high- and low-income individuals' consumption of insured ser-
vices; and the way the tort system distributes its costs (equally) and
benefits (unequally, at least insofar as it compensates for lost income).
To be sure, empirical evidence is lacking concerning how much more,
or less, care certain income groups consume than they pay for; indeed,
one wonders why researchers have not studied such questions. But
there are simply too many respects in which the American health care
system appears to serve elite interests at the expense of the great ma-
jority of (ignorant) consumers/employees/voters, who are not only
denied by law the chance to opt for cheap health coverage (with pub-
lic subsidies ensuring basic adequacy) but often forced by the high
cost to forgo health coverage altogether.
My son, preparing for a test in middle school, once asked me to
define "economics." My answer, "the study of scarcity," earned him
no credit with his teacher. Likewise, my idea that public policy
should view health care as a scarce resource, like other consumer
goods, has been widely deemed politically incorrect in the legal acad-
emy. That, at least, is the conclusion I have drawn from seeing how
skeptically my work embodying that idea has been received by many
health law scholars. I have always understood, of course, why the
explicitly political world, which trades in symbolism and populist
appeals to voters' apparent self-interest, finds it impossible to ac-
knowledge that health care, because its costs frequently exceed its
probable (though seldom its hypothesized) benefits, should sometimes
be unavailable to people seemingly in need of it. But the rest of the
legal world in general, and academic lawyers in particular, have no
comparable excuse for resisting the notion that individuals, appropri-
ately subsidized by society, should be allowed to choose their health
care-and, if they see fit, to economize by agreeing in advance to
38 See, e.g., Rush Prudential HMO, Inc. v. Moran, 122 U.S. 2151 (2002)
(allowing HMO member to obtain at plan expense, through perseverance and pro-
tracted litigation, costly services that other plan members, paying the same premiums,
would have had no realistic prospect of receiving in similar circumstances).
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forgo marginally valuable services. I find it ironic that so many who
think of themselves as progressives can dismiss my ideas so easily,
even when I am expressing concern about the welfare-not just the
health care, to be sure-of the very people they profess to care about
most. 39  The crowning irony, for me, is that, while many scholars
seem to marginalize me as a conservative, I have been more accu-
rately characterized as "a radical" who "take[s] consumers' rights
seriously."40
In any event, it has been a privilege to spend a career worrying, as
conscientiously and constructively as I know how, about issues as
consequential as those encountered in health care law and policy.
Even though I regret that the nation has not embraced the democratic
idea that people should be free, trusted, and expected to choose for
themselves (above a floor guaranteed by public subsidies) the health
care that best suits their circumstances, I remain encouraged that the
nation has not definitively taken a different policy direction. Instead,
national health policy has become mostly incoherent, just as health
care law remains, as I explained in a 2000 overview, a mass of
"anomalies and fundamental contradictions [that] reflect a high degree
of cognitive dissonance both in public attitudes toward health care and
in health policy itself."4' Under such unsettled and unstable circum-
stances-and with the uninsured a matter of continuing, even increas-
ing, concern-it is not unreasonable to think that dramatic happen-
ings, both in the private sector and in the political sphere, will eventu-
ally reopen the search for ways to put American health care finally on
a sound economic footing while also honoring a commitment to en-
sure everyone a reasonable minimum level of care. Because cost-
39 Just after writing this thought (and the previous paragraph), I was struck
by the following from a review of a recent book by a respected political scientist:
"Her rebuke to today's liberals is that while they don the mantle of democratic egali-
tarianism, they actually represent the outlook of upper-middle-class elites who have
decoupled their policy agenda from the concrete interests of the lower-middle class
and the working poor." William A. Galston, The New Class vs. Social Democracy,
PUB. INT., Fall 2003, at 100, 102 (reviewing THEDA SKOCPOL, DIMINISHED
DEMOCRACY: FROM MEMBERSHIP TO MANAGEMENT IN AMERICAN Civic LIFE (2003)).
40 See James C. Robinson, Taking Consumers' Rights Seriously, HEALTH
AFF., Fall 1996, at 277 (reviewing my book, Health Care Choices):
Clark Havighurst is a radical. His new book . . . rages like the rivers Al-
pheus and Peneus through the Augean stables of health policy discourse,
filled as they are with intellectual leavings of medical, legal, and bureau-
cratic elites that for decades have denied consumers their rights under the
pretense of promoting those rights and enfeebled the citizenry under the
pretense of protecting it.
Until I read Professor Robinson's striking simile, I had never thought of the task I set
for myself as Herculean.
41 Havighurst, supra note 34, at 86.
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constrained consumer choice is still the most promising, practical, and
democratic tool we have for breaking the hammerlock of unrealistic,
legally guaranteed entitlements and for making both private health
coverage and publicly financed universal coverage affordable, the
time may eventually come for ideas like mine-unthinkable as they
still seem to be for many observers.42
42 Perhaps, however, what we have witnessed in the last thirty years is an
example of the cyclical nature, observed by Calabresi and Bobbitt, of public policies
affecting so-called tragic choices. GUIDO CALABRESI & PHILIP BOBBITT, TRAGIC
CHOICES (1978). Their insightful observation was that there are some situations
(tragic choices) in which, even though economic efficiency may clearly dictate that
unlucky individuals should bear some serious hardships rather than having them
prevented or alleviated by public action, our political and legal institutions cannot,
and will not, indefinitely accept such apparently avoidable tragedies. In their view,
public policy in such cases is destined to evolve endlessly in cycles, emphasizing at
each stage some value--efficiency, compassion, fairness, or openness, for example,
that previous policy had neglected. I wonder if other scholars working in the health
policy field feel diminished, as I do, by the possibility that we are only playing transi-
tory roles in an unending drama that has no denouement, only scenes that, however
satisfyingly or unsatisfyingly any one of them may end, leave the policy result still
unsettled and unstable. Is it true, as the Calabresi/Bobbitt hypothesis suggests, that
seriously consequential choices can never be permanently removed from the public
agenda and placed finally (with subsidies) in private hands? Although I am not con-
vinced that things are necessarily that way in health policy, recent events and many
aspects of the political economy of health care certainly suggest that we may never
get health policy right.
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